213 related articles for article (PubMed ID: 15170731)
21. Toxicity of repeated intravenous injection of gene therapeutics for X-CGD in mice.
Lee YM; Choi WH; Kim YB; Ha CS; Song CW; Lee M; Joo CW; Hong Y; Ho SH; Kim S; Kim JM; Koh WS
Hum Exp Toxicol; 2008 May; 27(5):401-7. PubMed ID: 18715886
[TBL] [Abstract][Full Text] [Related]
22. Retroviral hybrid LTR vector strategy: functional analysis of LTR elements and generation of endothelial cell specificity.
Richardson TB; Kaspers J; Porter CD
Gene Ther; 2004 May; 11(9):775-83. PubMed ID: 14999228
[TBL] [Abstract][Full Text] [Related]
23. Genotoxicity of retroviral integration in hematopoietic cells.
Nienhuis AW; Dunbar CE; Sorrentino BP
Mol Ther; 2006 Jun; 13(6):1031-49. PubMed ID: 16624621
[TBL] [Abstract][Full Text] [Related]
24. Retroviral vectors for the transduction of autoregulated, bidirectional expression cassettes.
Unsinger J; Kröger A; Hauser H; Wirth D
Mol Ther; 2001 Nov; 4(5):484-9. PubMed ID: 11708885
[TBL] [Abstract][Full Text] [Related]
25. Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease.
Rappa G; Anzanello F; Alexeyev M; Fodstad O; Lorico A
Eur J Haematol; 2007 May; 78(5):440-8. PubMed ID: 17331133
[TBL] [Abstract][Full Text] [Related]
26. Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma.
Barzon L; Gnatta E; Castagliuolo I; Trevisan M; Moretti F; Pontecorvi A; Boscaro M; Palù G
Cancer Gene Ther; 2005 Apr; 12(4):381-8. PubMed ID: 15650765
[TBL] [Abstract][Full Text] [Related]
27. Radioprotective gene therapy through retroviral expression of manganese superoxide dismutase.
Southgate TD; Sheard V; Milsom MD; Ward TH; Mairs RJ; Boyd M; Fairbairn LJ
J Gene Med; 2006 May; 8(5):557-65. PubMed ID: 16506247
[TBL] [Abstract][Full Text] [Related]
28. Adenovirus-mediated gene transfer into monocyte-derived macrophages of patients with X-linked chronic granulomatous disease: ex vivo correction of deficient respiratory burst.
Schneider SD; Rusconi S; Seger RA; Hossle JP
Gene Ther; 1997 Jun; 4(6):524-32. PubMed ID: 9231068
[TBL] [Abstract][Full Text] [Related]
29. Stable and strictly controlled expression of LTR-flanked autoregulated expression cassettes upon adenoviral transfer.
Unsinger J; Lindenmaier W; May T; Hauser H; Wirth D
Biochem Biophys Res Commun; 2004 Jul; 319(3):879-87. PubMed ID: 15184065
[TBL] [Abstract][Full Text] [Related]
30. Self-inactivating retroviral vectors with improved RNA processing.
Kraunus J; Schaumann DH; Meyer J; Modlich U; Fehse B; Brandenburg G; von Laer D; Klump H; Schambach A; Bohne J; Baum C
Gene Ther; 2004 Nov; 11(21):1568-78. PubMed ID: 15372067
[TBL] [Abstract][Full Text] [Related]
31. Genetic correction of X-linked chronic granulomatous disease with novel foamy virus vectors.
Chatziandreou I; Siapati EK; Vassilopoulos G
Exp Hematol; 2011 Jun; 39(6):643-52. PubMed ID: 21426924
[TBL] [Abstract][Full Text] [Related]
32. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
33. The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production.
Bellantuono I; Lashford LS; Rafferty JA; Fairbairn LJ
Haematologica; 2000 May; 85(5):451-7. PubMed ID: 10800158
[TBL] [Abstract][Full Text] [Related]
34. Optimization of regulated LTR-mediated expression.
Lorens JB; Jang Y; Rossi AB; Payan DG; Bogenberger JM
Virology; 2000 Jun; 272(1):7-15. PubMed ID: 10873744
[TBL] [Abstract][Full Text] [Related]
35. The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors.
Higashimoto T; Urbinati F; Perumbeti A; Jiang G; Zarzuela A; Chang LJ; Kohn DB; Malik P
Gene Ther; 2007 Sep; 14(17):1298-304. PubMed ID: 17597793
[TBL] [Abstract][Full Text] [Related]
36. Generation of a high titre retroviral vector for endothelial cell-specific gene expression in vivo.
Mavria G; Jäger U; Porter CD
Gene Ther; 2000 Mar; 7(5):368-76. PubMed ID: 10694818
[TBL] [Abstract][Full Text] [Related]
37. Construction of retroviral vectors with enhanced efficiency of transgene expression.
Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
[TBL] [Abstract][Full Text] [Related]
39. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
Malik P; Arumugam PI; Yee JK; Puthenveetil G
Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy of chronic granulomatous disease.
Grez M; Becker S; Saulnier S; Knöss H; Ott MG; Maurer A; Dinauer MC; Hoelzer D; Seger R; Hossle JP
Bone Marrow Transplant; 2000 May; 25 Suppl 2():S99-104. PubMed ID: 10933200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
